Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation.
KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.
Kate Farms offers plant-based shakes and formulas for tube-fed adults and children.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Biosyntia is a biotech startup within synthetic biology and metabolic engineering.
Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.
Roslin Technologies is a biotechnology company that focuses on developing technologies for the agricultural and animal health sectors.
Inspirna is a biotechnology company developing drugs for the treatment of cancer.
Swift Health Systems is a stealth stage start-up medical device company, developing INBRACE.
Based on our deep science and focused on patients in need.
The Protein Brewery specializes in developing and making animal-free-based protein in a sustainable way.
CorWave is a medical device company developing innovative heart pumps.
Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.
Novo Holdings has invested in 215 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novo Holdings's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Biopharma. The firm invests across 27 different industry categories.
Among tracked funding rounds, Tempus received $400.0M in a Post-IPO Debt round. Novo Holdings's total known invested capital is $15.3B.
Novo Holdings's average investment size is $82.9M across its portfolio of 215 companies.
Recent Novo Holdings portfolio additions include Tarveda Therapeutics, Acesion Pharma, KalVista Pharmaceuticals, Kate Farms, MapLight Therapeutics. These companies were founded in 2020 or later.